Cited by 616Amyotrophic Lateral Sclerosis ResearchHereditary Neurological DisordersAlzheimer's disease research and treatments

The DOI matches its Crossref record; 201 of the 202 references it cites were found in a registry or an index.

Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis

Open access

Ferraiuolo, Laura, Kirby, Janine, Grierson, Andrew J., Sendtner, Michael, Shaw, Pamela J.·2011·Nature Reviews Neurology

DOI 10.1038/nrneurol.2011.152

Open this paper in CoChat — free account

Abstract

Amyotrophic lateral sclerosis (ALS) is a genetically diverse disease. At least 15 ALS-associated gene loci have so far been identified, and the causative gene is known in approximately 30% of familial ALS cases. Less is known about the factors underlying the sporadic form of the disease. The molecular mechanisms of motor neuron degeneration are best understood in the subtype of disease caused by mutations in superoxide dismutase 1, with a current consensus that motor neuron injury is caused by a complex interplay between multiple pathogenic processes. A key recent finding is that mutated TAR DNA-binding protein 43 is a major constituent of the ubiquitinated protein inclusions in ALS, providing a possible link between the genetic mutation and the cellular pathology. New insights have also indicated the importance of dysregulated glial cell-motor neuron crosstalk, and have highlighted the vulnerability of the distal axonal compartment early in the disease course. In addition, recent studies have suggested that disordered RNA processing is likely to represent a major contributing factor to motor neuron disease. Ongoing research on the cellular pathways highlighted in this Review is predicted to open the door to new therapeutic interventions to slow disease progression in ALS.

Integrity signals

Registry

Crossref · 10.1038/nrneurol.2011.152

Cites

201 of 201 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 retracted

RETRACTED: Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis
Atkin, J. D., Farg, M. A., Walker, A. K., McLean, C., Tomas, D., & Horne, M. K. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.02.009 · Cited by 350
Retracted
Induction of the Unfolded Protein Response in Familial Amyotrophic Lateral Sclerosis and Association of Protein-disulfide Isomerase with Superoxide Dismutase 1
Atkin, J. D., Farg, M. A., Turner, B. J., Tomas, D., Lysaght, J. A., Nunan, J., Rembach, A., Nagley, P., Beart, P. M., Cheema, S. S., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603393200 · Cited by 289
Retracted
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Self-citation
Identification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Bénichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,995
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., et al. (2008) · Science · doi:10.1126/science.1154584 · Cited by 2,630
Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
Vance, C. A., Rogelj, B., Hortobágyi, T., Vos, K. J. D., Nishimura, A. L., Sreedharan, J., Hu, X., Smith, B. N., Ruddy, D., Wright, P. D., et al. (2009) · Science · doi:10.1126/science.1165942 · Cited by 2,625

Flagged first, then by citations

Show all 202 references

1 of the 202 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

Fitzmaurice, P. S. et al. Evidence for DNA damage in amyotrophic lateral sclerosis. Muscle Nerve 19, 797–798 (1996).
Highley, J. R. et al. TARDBP mutations, amyotrophic lateral sclerosis and alternative splicing in human fibroblasts. Brain Pathol. 20 (Suppl. 1), 32 (2010).

Sorted by citations

Items 101–200 of 616

DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity
Kok, J. R., Palminha, N. M., Souza, C. D. S., El‐Khamisy, S. F., & Ferraiuolo, L. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03872-0 · Cited by 89
Self-citation
Mutant TDP-43 Deregulates AMPK Activation by PP2A in ALS Models
Perera, N. D., Sheean, R. K., Scott, J. W., Kemp, B. E., Horne, M. K., & Turner, B. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090449 · Cited by 82
The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients
Yamashita, T., & Kwak, S. (2013) · Brain Research · doi:10.1016/j.brainres.2013.12.011 · Cited by 84
Calcium Channel Agonists Protect against Neuromuscular Dysfunction in a Genetic Model of TDP-43 Mutation in ALS
Armstrong, G. A. B., & Drapeau, P. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4003-12.2013 · Cited by 84
Altered Mitochondrial Dynamics in Motor Neuron Disease: An Emerging Perspective
Kodavati, M. M., Wang, H., & Hegde, M. L. (2020) · Cells · doi:10.3390/cells9041065 · Cited by 87
Silencing strategies for therapy of SOD1-mediated ALS
van Zundert, B., & Brown, R. H. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.07.059 · Cited by 81
The Extracellular Domain of Neurotrophin Receptor p75 as a Candidate Biomarker for Amyotrophic Lateral Sclerosis
Shepheard, S. R., Chataway, T., Schultz, D. W., Rush, R. A., & Rogers, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087398 · Cited by 79
RNA-binding proteins in neurological diseases
Zhou, H.-L., Mangelsdorf, M., Liu, J., Zhu, L., & Wu, J. Y. (2014) · Science China Life Sciences · doi:10.1007/s11427-014-4647-9 · Cited by 82
Identification of rare protein disulfide isomerase gene variants in amyotrophic lateral sclerosis patients
González-Pérez, P., Woehlbier, U., Chian, R.-J., Sapp, P. C., Rouleau, G. A., Leblond, C. S., Daoud, H., Dion, P. A., Landers, J. E., Hetz, C. A., et al. (2015) · Gene · doi:10.1016/j.gene.2015.04.035 · Cited by 79
Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection
Cha, S. J., & Kim, K. (2022) · Antioxidants · doi:10.3390/antiox11020195 · Cited by 78
Defective Proteasome Delivery of Polyubiquitinated Proteins by Ubiquilin-2 Proteins Containing ALS Mutations
Chang, L., & Monteiro, M. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130162 · Cited by 80
Therapeutic Development in Amyotrophic Lateral Sclerosis
Bucchia, M., Ramirez, A., Parente, V., Simone, C., Nizzardo, M., Magri, F., Dametti, S., & Corti, S. P. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.12.020 · Cited by 78
A stocked toolbox for understanding the role of astrocytes in disease
Almad, A., & Maragakis, N. J. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0010-2 · Cited by 80
Exploring new pathways of neurodegeneration in ALS: The role of mitochondria quality control
Palomo, G. M., & Manfredi, G. (2014) · Brain Research · doi:10.1016/j.brainres.2014.09.065 · Cited by 81
Unique biology of gliomas: challenges and opportunities
Watkins, S., & Sontheimer, H. W. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.05.001 · Cited by 76
New pathogenic insights from large animal models of neurodegenerative diseases
Yin, P., Li, S., Li, X., & Yang, W. (2022) · Protein & Cell · doi:10.1007/s13238-022-00912-8 · Cited by 79
The physiological and pathophysiological roles of copper in the nervous system
Gale, J. R., & Aizenman, E. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16370 · Cited by 85
Early Functional Deficit and Microglial Disturbances in a Mouse Model of Amyotrophic Lateral Sclerosis
Gerber, Y. N., Sabourin, J.-C., Rábano, M., Vivanco, M. D., & Perrin, F. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036000 · Cited by 76
Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis
Verbeeck, C., Deng, Q., DeJesus‐Hernandez, M., Taylor, G., Ceballos‐Diaz, C., Kocerha, J., Golde, T. E., Das, P., Rademakers, R., Dickson, D. W., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-53 · Cited by 79
The Role of Rab Proteins in Neuronal Cells and in the Trafficking of Neurotrophin Receptors
Bucci, C., Alifano, P., & Cogli, L. (2014) · Membranes · doi:10.3390/membranes4040642 · Cited by 77
Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase
Lewis, K. E. A., Rasmussen, A. L., Bennett, W. R., King, A. E., West, A. K., Chung, R. S., & Chuah, M. I. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-55 · Cited by 77
Autophagy and Neurodegeneration: Insights from a Cultured Cell Model of ALS
Navone, F., Genevini, P., & Borgese, N. (2015) · Cells · doi:10.3390/cells4030354 · Cited by 74
Disruption of ER−mitochondria signalling in fronto-temporal dementia and related amyotrophic lateral sclerosis
Lau, D. H. W., Hartopp, N., Welsh, N. J., Mueller, S., Glennon, E. B. C., Mórotz, G. M., Annibali, A., Gómez‐Suaga, P., Stoica, R., Paillusson, S., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0022-7 · Cited by 77
CX3CR1 Is a Modifying Gene of Survival and Progression in Amyotrophic Lateral Sclerosis
López-López, A., Gámez, J., Syriani, E., Morales, M., Salvadó, M., Rodríguez, M. J., Mahy, N., & Vidal-Taboada, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096528 · Cited by 74
The amyotrophic lateral sclerosis 8 protein, VAP, is required for ER protein quality control
Moustaqim‐Barrette, A., Lin, Y. Q., Pradhan, S., Neely, G. G., Bellen, H. J., & Tsuda, H. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt594 · Cited by 71
Targeting glial cannabinoid CB2 receptors to delay the progression of the pathological phenotype in TDP‐43 ( A315T ) transgenic mice, a model of amyotrophic lateral sclerosis
Espejo‐Porras, F., García‐Toscano, L., Rodríguez‐Cueto, C., Santos‐García, I., de Lago, E., & Fernández‐Ruíz, J. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14216 · Cited by 74
The Key Role of Astrocytes in Amyotrophic Lateral Sclerosis and Their Commitment to Glutamate Excitotoxicity
Provenzano, F., Torazza, C., Bonifacino, T., Bonanno, G., & Milanese, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015430 · Cited by 78
Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice
Chen, Y., Guan, Y., Zhang, Z., Liu, H., Wang, S., Yu, L., Wu, X., & Wang, X. (2012) · Neurological Research · doi:10.1179/1743132812y.0000000027 · Cited by 68
The latest progress on miR‐374 and its functional implications in physiological and pathological processes
Bian, H., Zhou, Y., Zhou, D., Zhang, Y., Shang, D., & Qi, J. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14219 · Cited by 69
Implications of Microglia in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Haukedal, H., & Freude, K. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.02.004 · Cited by 68
Protein aggregation and therapeutic strategies in SOD1- and TDP-43- linked ALS
Tsekrekou, M., Giannakou, M., Papanikolopoulou, K., & Σκρέτας, Γ. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1383453 · Cited by 71
Traumatic Brain Injury Results in Cellular, Structural and Functional Changes Resembling Motor Neuron Disease
Wright, D. K., Liu, S., van der Poel, C., McDonald, S. J., Brady, R. D., Taylor, L., Yang, L., Gardner, A. J., Ordidge, R. J., O'Brien, T. J., et al. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw254 · Cited by 70
Differential roles of α-, β-, and γ-actin in axon growth and collateral branch formation in motoneurons
Moradi, M., Sivadasan, R., Saal-Bauernschubert, L., Lüningschrör, P., Dombert, B., Rathod, R. J., Dieterich, D. C., Blum, R., & Sendtner, M. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201604117 · Cited by 67
Self-citation
Dynamic changes of CX3CL1/CX3CR1 axis during microglial activation and motor neuron loss in the spinal cord of ALS mouse model
Zhang, J., Liu, Y., Liu, X., Li, S., Cheng, C., Chen, S., & Le, W. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0138-4 · Cited by 57
Androgen Therapy in Neurodegenerative Diseases
Bianchi, V. E., Rizzi, L., Bresciani, E., Omeljaniuk, R. J., & Torsello, A. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa120 · Cited by 69
Molecular Chaperones, Alpha-Synuclein, and Neurodegeneration
Witt, S. N. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8325-2 · Cited by 68
A new zebrafish model produced by TILLING of SOD1-related amyotrophic lateral sclerosis replicates key features of the disease and represents a tool for in vivo therapeutic screening
Costa, M. D., Allen, C. E., Higginbottom, A., Ramesh, T., Shaw, P. J., & McDermott, C. J. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.012013 · Cited by 65
Self-citation
Biomarkers of Amyotrophic Lateral Sclerosis: Current Status and Interest of Oxysterols and Phytosterols
Véjux, A., Namsi, A., Nury, T., Moreau, T., & Lizard, G. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00012 · Cited by 65
Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning
Kumar, V., Islam, A., Hassan, M. I., & Ahmad, F. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.06.017 · Cited by 69
Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1G93A transgenic mice, an experimental model of amyotrophic lateral sclerosis
Rodríguez‐Cueto, C., Santos‐García, I., García‐Toscano, L., Espejo‐Porras, F., Bellido, M., Fernández‐Ruíz, J., Muñóz, E., & de Lago, E. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.049 · Cited by 66
R13 preserves motor performance in SOD1 G93A mice by improving mitochondrial function
Li, X., Chen, C., Xu, Z., Li, B., Zhang, Z., Li, S., Xie, Y., Song, X., Shen, Y., Liu, J., et al. (2021) · Theranostics · doi:10.7150/thno.56070 · Cited by 64
Copper ion / H2O2 oxidation of Cu/Zn-Superoxide dismutase: Implications for enzymatic activity and antioxidant action
Tiwari, M. K., Hägglund, P., Møller, I. M., Davies, M. J., & Bjerrum, M. J. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101262 · Cited by 62
Mitochondrial Permeability Transition, Cell Death and Neurodegeneration
Baev, A. Y., Vinokurov, A. Y., Potapova, E., Dunaev, A., Angelova, P. R., & Abramov, A. Y. (2024) · Cells · doi:10.3390/cells13070648 · Cited by 67
Molecular Chaperone Mediated Late-Stage Neuroprotection in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
Novoselov, S. S., Mustill, W. J., Gray, A. L., Dick, J. R. T., Kanuga, N., Kalmár, B., Greensmith, L., & Cheetham, M. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073944 · Cited by 67
Neurochemical correlation between major depressive disorder and neurodegenerative diseases
Réus, G. Z., Titus, S. E., Abelaira, H. M., Freitas, S. M., Tuon, T., Quevedo, J., & Budni, J. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.06.027 · Cited by 67
Cold temperature extends longevity and prevents disease-related protein aggregation through PA28γ-induced proteasomes
Lee, H. J., Alirzayeva, H., Koyuncu, S., Rueber, A., Noormohammadi, A., & Vílchez, D. (2023) · Nature Aging · doi:10.1038/s43587-023-00383-4 · Cited by 63
Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders
Espejo‐Porras, F., Piscitelli, F., Verde, R., Ramos, J. A., Marzo, V. D., de Lago, E., & Fernández‐Ruíz, J. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9602-4 · Cited by 62
Humoral immunity response to human endogenous retroviruses K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases
Arru, G., Mameli, G., Deiana, G. A., Rassu, A. L., Piredda, R., Sechi, E., Caggiu, E., Bo, M., Nako, E., Urso, D., et al. (2018) · European Journal of Neurology · doi:10.1111/ene.13648 · Cited by 60
Human endogenous retroviruses in neurologic disease
Christensen, T. (2016) · Apmis · doi:10.1111/apm.12486 · Cited by 62
Dysregulation of the Autophagy-Endolysosomal System in Amyotrophic Lateral Sclerosis and Related Motor Neuron Diseases
Otomo, A., Pan, L., & Hadano, S. (2012) · Neurology Research International · doi:10.1155/2012/498428 · Cited by 63
Triheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral Sclerosis
Tefera, T. W., Wong, Y., Barkl‐Luke, M. E., Ngo, S. T., Thomas, N. K., McDonald, T. S., & Borges, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161816 · Cited by 61
A Case for Microtubule Vulnerability in Amyotrophic Lateral Sclerosis: Altered Dynamics During Disease
Clark, J. A., Yeaman, E. J., Blizzard, C. A., Chuckowree, J. A., & Dickson, T. C. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00204 · Cited by 66
Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker study
van Rheenen, W., Diekstra, F. P., Harschnitz, O., Westeneng, H., van Eijk, K. R., Saris, C. G. J., Groen, E. J. N., van Es, M. A., Blauw, H. M., van Vught, P. W. J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198874 · Cited by 61
Genetics of Familial Amyotrophic Lateral Sclerosis
Emily, F., Joanna, J., Cooper‐Knock, J., Pamela, J., & Kirby, J. (2012) · InTech eBooks · doi:10.5772/32498 · Cited by 60
Self-citation
Downregulated AEG-1 together with inhibited PI3K/Akt pathway is associated with reduced viability of motor neurons in an ALS model
Yin, X. L., Ren, M., Jiang, H.-Z., Cui, S., Wang, S., Jiang, H., Qi, Y., Wang, J., Wang, X., Dong, G., et al. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.08.009 · Cited by 61
Methyl pyruvate rescues mitochondrial damage caused by SIGMAR1 mutation related to amyotrophic lateral sclerosis
Tagashira, H., Shinoda, Y., Shioda, N., & Fukunaga, K. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.08.012 · Cited by 58
Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders
Qiang, L., Fujita, R., & Abeliovich, A. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.002 · Cited by 59
Tetramethylpyrazine nitrone improves motor dysfunction and pathological manifestations by activating the PGC-1α/Nrf2/HO-1 pathway in ALS mice
Wen, J., Li, S., Zheng, C., Wang, F., Luo, Y., Wu, L., Cao, J., Guo, B., Yu, P., Zhang, G., et al. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108380 · Cited by 59
Biomarker-Based Predictive Models for Prognosis in Amyotrophic Lateral Sclerosis
Su, X., Simmons, Z., Mitchell, R. M., Kong, L., Stephens, H., & Connor, J. R. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.4646 · Cited by 59
Species-dependent neuropathology in transgenic SOD1 pigs
Yang, H., Wang, G., Sun, H., Shu, R., Liu, T., Wang, C.-E., Liu, Z., Zhao, Y., Zhao, B., Ouyang, Z., et al. (2014) · Cell Research · doi:10.1038/cr.2014.25 · Cited by 59
Proteostasis disturbance in amyotrophic lateral sclerosis
Medinas, D. B., Valenzuela, V., & Hetz, C. A. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx274 · Cited by 67
Neuronal AChE splice variants and their non‐hydrolytic functions: redefining a target of AChE inhibitors?
Zimmermann, M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12359 · Cited by 60
Effect of lipid profile on prognosis in the patients with amyotrophic lateral sclerosis: Insights from the olesoxime clinical trial
Rafiq, M. K., Lee, E. C., Bradburn, M. J., McDermott, C. J., & Shaw, P. J. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1062517 · Cited by 58
Self-citation
ADSC Therapy in Neurodegenerative Disorders
Chan, T.-M., Chen, J. Y.-R., Ho, L.-I., Lin, H.-P., Hsueh, K.-W., Liu, D. D., Chen, Y.-H., Hsieh, A.-C., Tsai, N., Hueng, D., et al. (2014) · Cell Transplantation · doi:10.3727/096368914x678445 · Cited by 57
ALS-linked mutations in ubiquilin-2 or hnRNPA1 reduce interaction between ubiquilin-2 and hnRNPA1
Gilpin, K. M., Chang, L., & Monteiro, M. J. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv020 · Cited by 58
Synthetic and natural small molecule TLR4 antagonists inhibit motoneuron death in cultures from ALS mouse model
Paola, M. D., Sestito, S. E., Mariani, A., Memo, C., Fanelli, R., Freschi, M., Bendotti, C., Calabrese, V., & Peri, F. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.11.020 · Cited by 58
Glycoursodeoxycholic Acid Reduces Matrix Metalloproteinase-9 and Caspase-9 Activation in a Cellular Model of Superoxide Dismutase-1 Neurodegeneration
Vaz, A. R., Cunha, C., Gomes, C., Schmucki, N., Barbosa, M., & Brites, D. M. T. O. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8731-8 · Cited by 57
Neuroprotective Effect of Bexarotene in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
Riancho, J., Ruiz‐Soto, M., Berciano, M. T., Berciano, J., & Lafarga, M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00250 · Cited by 57
Imaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral Sclerosis
Mazón, M., Vazquez-Costa, J. F., Ten‐Esteve, A., & Martí‐Bonmatí, L. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00784 · Cited by 56
Mutant superoxide dismutase 1 (SOD1), a cause of amyotrophic lateral sclerosis, disrupts the recruitment of SMN, the spinal muscular atrophy protein to nuclear Cajal bodies
Kariya, S., Ré, D. B., Jacquier, A., Nelson, K. N., Przedborski, S., & Monani, U. R. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds174 · Cited by 54
Neuritogenic Militarinone‐Inspired 4‐Hydroxypyridones Target the Stress Pathway Kinase MAP4K4
Schröder, P., Förster, T., Kleine, S., Becker, C. J., Richters, A., Ziegler, S., Rauh, D., Kumar, K., & Waldmann, H. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201501515 · Cited by 55
¿Por qué degeneran las motoneuronas? Actualización en la patogenia de la esclerosis lateral amiotrófica
Riancho, J., Gonzalo, I., Ruiz‐Soto, M., & Berciano, J. (2016) · Neurología · doi:10.1016/j.nrl.2015.12.001 · Cited by 65
Network Analyses Reveal Novel Aspects of ALS Pathogenesis
Sanhueza, M., Chai, A., Smith, C., McCray, B. A., Simpson, T. I., Taylor, J. P., & Pennetta, G. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005107 · Cited by 53
The Spectrum of C9orf72-mediated Neurodegeneration and Amyotrophic Lateral Sclerosis
Cooper‐Knock, J., Kirby, J., Highley, J. R., & Shaw, P. J. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0342-1 · Cited by 58
Self-citation
Dysfunction of Mitochondrial Ca2+ Regulatory Machineries in Brain Aging and Neurodegenerative Diseases
Jung, H., Kim, S. Y., Cecen, F. S. C., Cho, Y., & Kwon, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.599792 · Cited by 56
Evidence for an early innate immune response in the motor cortex of ALS
Jara, J. H., Genç, B., Stanford, M. J., Pytel, P., Roos, R. P., Weıntraub, S., Mesulam, M. M., Bigio, E. H., Miller, R. J., & Özdi̇nler, P. H. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0896-4 · Cited by 58
Roles of Vascular Endothelial Growth Factor in Amyotrophic Lateral Sclerosis
Pronto‐Laborinho, A. C., Pinto, S., & de Carvalho, M. A. (2014) · BioMed Research International · doi:10.1155/2014/947513 · Cited by 55
The role of d-amino acids in amyotrophic lateral sclerosis pathogenesis: a review
Paul, P., & de Belleroche, J. (2012) · Amino Acids · doi:10.1007/s00726-012-1385-9 · Cited by 50
Deep Proteomic Evaluation of Primary and Cell Line Motoneuron Disease Models Delineates Major Differences in Neuronal Characteristics
Hornburg, D., Drepper, C., Butter, F., Meissner, F., Sendtner, M., & Mann, M. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.037291 · Cited by 53
Self-citation
Dysregulated expression of lipid storage and membrane dynamics factors in Tia1 knockout mouse nervous tissue
Heck, M. V., Azizov, M., Stehning, T., Walter, M. J., Kedersha, N., & Auburger, G. W. J. (2014) · Neurogenetics · doi:10.1007/s10048-014-0397-x · Cited by 54
Specific Physical Exercise Improves Energetic Metabolism in the Skeletal Muscle of Amyotrophic-Lateral- Sclerosis Mice
Desseille, C., Deforges, S., Biondi, O., Houdebine, L., D’amico, D., Lamazière, A., Caradeuc, C., Bertho, G., Bruneteau, G., Weill, L., et al. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00332 · Cited by 50
Inflammation-dependent oxidative stress metabolites as a hallmark of amyotrophic lateral sclerosis
Xiong, L., McCoy, M. G., Komuro, H., West, X. Z., Yakubenko, V. P., Gao, D., Dudiki, T., Milo, A., Chen, J. M., Podrez, E. A., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.11.031 · Cited by 51
Association studies indicate that protein disulfide isomerase is a risk factor in amyotrophic lateral sclerosis
Kwok, C. T., Morris, A. G., Frampton, J., Smith, B. N., Shaw, C. E., & de Belleroche, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.001 · Cited by 50
MTHFSD and DDX58 are novel RNA-binding proteins abnormally regulated in amyotrophic lateral sclerosis
MacNair, L., Xiao, S., Miletic, D., Ghani, M., Julien, J., Keith, J. L., Zinman, L. H., Rogaeva, E. A., & Robertson, J. (2015) · Brain · doi:10.1093/brain/awv308 · Cited by 49
Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis
Milanese, M., Giribaldi, F., Melone, M., Bonifacino, T., Musante, I., Carminati, E., Rossi, P. I. A., Vergani, L., Voci, A., Conti, F., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.11.006 · Cited by 50
Translating SOD1 Gene Silencing toward the Clinic: A Highly Efficacious, Off-Target-free, and Biomarker-Supported Strategy for fALS
Iannitti, T., Scarrott, J. M., Likhite, S. B., Coldicott, I., Lewis, K. E. A., Heath, P. R., Higginbottom, A., Myszczynska, M. A., Milo, M., Hautbergue, G. M., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.04.015 · Cited by 50
Self-citation
Viral Delivery of Antioxidant Genes as a Therapeutic Strategy in Experimental Models of Amyotrophic Lateral Sclerosis
Nanou, A., Higginbottom, A., Valori, C. F., Wyles, M., Ning, K., Shaw, P. J., & Azzouz, M. (2013) · Molecular Therapy · doi:10.1038/mt.2013.115 · Cited by 50
Self-citation
Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1
Tokuda, E., Okawa, E., Watanabe, S., & Ono, S.-I. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt517 · Cited by 48
Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with 18F-DPA-714 and micro-PET/CT
Gargiulo, S., Anzilotti, S., Coda, A. R. D., Gramanzini, M., Greco, A., Panico, M., Vinciguerra, A., Zannetti, A., Vicidomini, C., Dollé, F., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3311-y · Cited by 48
Prediction of Functional Loss of Human Angiogenin Mutants Associated with ALS by Molecular Dynamics Simulations
Padhi, A. K., Jayaram, B., & Gomes, J. (2013) · Scientific Reports · doi:10.1038/srep01225 · Cited by 48
Computational approaches to understanding protein aggregation in neurodegeneration
Redler, R. L., Shirvanyants, D. G., Dağliyan, O., Ding, F., Kim, D. N., Kota, P. B., Proctor, E. A., Ramachandran, S., Tandon, A., & Dokholyan, N. V. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mju007 · Cited by 47
Inflammation and neuronal death in the motor cortex of the wobbler mouse, an ALS animal model
Dahlke, C., Saberi, D., Ott, B., Brand‐Saberi, B., Schmitt‐John, T., & Theiß, C. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0435-0 · Cited by 47
Severe muscle wasting and denervation in mice lacking the RNA-binding protein ZFP106
Anderson, D. M., Cannavino, J., Li, H. Z., Anderson, K. M., Nelson, B. R., McAnally, J., Bezprozvannaya, S., Liu, Y., Lin, W., Liu, N., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608423113 · Cited by 46
Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design
Sehgal, S. A., Hammad, M. A., Tahir, R. A., Akram, H. N., & Ahmad, F. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180315142137 · Cited by 47
Overexpression of miR-124 in Motor Neurons Plays a Key Role in ALS Pathological Processes
Vaz, A. R., Vizinha, D., Morais, H. M. M., Colaço, A. R. A., Loch-Neckel, G., Barbosa, M., & Brites, D. M. T. O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116128 · Cited by 48
Altered age-related changes in bioenergetic properties and mitochondrial morphology in fibroblasts from sporadic amyotrophic lateral sclerosis patients
Allen, S. P., Duffy, L. M., Shaw, P. J., & Grierson, A. J. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.07.013 · Cited by 47
Self-citation
Lysosomal and phagocytic activity is increased in astrocytes during disease progression in the SOD1 G93A mouse model of amyotrophic lateral sclerosis
Baker, D. J., Blackburn, D. J., Keatinge, M., Sokhi, D. S., Viskaitis, P., Heath, P. R., Ferraiuolo, L., Kirby, J., & Shaw, P. J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00410 · Cited by 48
Self-citation
Advances in the Development of Disease-Modifying Treatments for Amyotrophic Lateral Sclerosis
Moujalled, D., & White, A. R. (2016) · CNS Drugs · doi:10.1007/s40263-016-0317-8 · Cited by 48
Nuclear TDP-43 causes neuronal toxicity by escaping from the inhibitory regulation by hnRNPs
Suzuki, H., Shibagaki, Y., Hattori, S., & Matsuoka, M. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu563 · Cited by 45
The Genetic Diagnosis of Neurodegenerative Diseases and Therapeutic Perspectives
Casallas, J. C. G., & Bustos, R. (2018) · Brain Sciences · doi:10.3390/brainsci8120222 · Cited by 49

Authors: Ferraiuolo, L., Kirby, J., Grierson, A. J., Sendtner, M., & Shaw, P. J.
Affiliations: University of Sheffield (GB)
University of Würzburg (DE)
Corresponding author: Shaw, Pamela J.
ORCID: Ferraiuolo, Laura
Kirby, Janine
Grierson, Andrew J.
Sendtner, Michael
Shaw, Pamela J.
Venue: Nature Reviews Neurology
Publisher: Springer Science and Business Media LLC
Published: 2011-11
Volume: 7
Issue: 11
Pages: 616-630
ISSN: 1759-4758 (ISSN-L)
1759-4766
DOI: 10.1038/nrneurol.2011.152
OpenAlex: W2025413109
Cited by: 615
References: 202
Citations by year: 2026: 12 · 2025: 24 · 2024: 34 · 2023: 25 · 2022: 27 · 2021: 54 · 2020: 34 · 2019: 37 · 2018: 33 · 2017: 42 · 2016: 58 · 2015: 63 · 2014: 63 · 2013: 64 · 2012: 45
FWCI: 6.83
Type: journal article
Language: en
Open access: green
zenodo.org
Licence: other-oa
www.springer.com/tdm (tdm)
Locations: Nature Reviews Neurology (publishedVersion)
PubMed (publishedVersion)
Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
Funders: Wellcome Trust
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: amyotrophic lateral sclerosis, motor neuron injury, motor neuron degeneration, oxidative stress, mitochondrial dysfunction, excitotoxicity, superoxide dismutase 1, TDP-43, sporadic ALS, familial ALS, therapeutic target
MeSH terms: Amyotrophic Lateral Sclerosis, Humans, Motor Neurons, Nerve Degeneration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks